SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-062388
Filing Date
2021-05-06
Accepted
2021-05-06 16:06:10
Documents
14
Period of Report
2021-05-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2115478d1_8k.htm   iXBRL 8-K 30652
2 EXHIBIT 99.1 tm2115478d1_ex99-1.htm EX-99.1 52744
6 GRAPHIC tm2115478d1_ex99-1img01.jpg GRAPHIC 19393
  Complete submission text file 0001104659-21-062388.txt   295213

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iova-20210506.xsd EX-101.SCH 3011
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iova-20210506_lab.xml EX-101.LAB 34238
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iova-20210506_pre.xml EX-101.PRE 22349
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2115478d1_8k_htm.xml XML 3618
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36860 | Film No.: 21897705
SIC: 2836 Biological Products, (No Diagnostic Substances)